Skip to search.
 TSX Down 1.30% TSX Ventures Down 1.82%

XOMA Corporation (XOMA)

-NasdaqGM
0.82 Down 0.12(12.51%) 4:00PM EDT
|After Hours : 0.82 Down 0.00 (0.49%) 7:19PM EDT
Add to Portfolio
Prev Close:0.94
Open:0.92
Bid:0.81 x 3000
Ask:0.82 x 500
1y Target Est:6.33
Beta:3.4
Next Earnings Date: 6-Aug-15XOMA Earnings announcement
Day's Range:0.79 - 0.94
52wk Range:0.79 - 5.95
Volume:13,799,381
Avg Vol (3m):5,434,780
Market Cap:97.08M
P/E (ttm):N/A
EPS (ttm):-0.69
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
XOMADown 12.51%97.08M
NVSDown 0.26%245.24B
REGNDown 0.34%56.84B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.13
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.64
Quarterly EPS Est (Jun-15) :-0.18
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-0.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company’s lead product candidate includes gevokizumab, a proprietary humanized allosteric-modulating monoclonal antibo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback